Correction to Reinterpreting the Mechanism of Inhibition of <i>Mycobacterium tuberculosis</i> d‑Alanine:d‑Alanine Ligase by d‑Cycloserin
<p>Correction: Selective Targeting of <i>CTNNB1-</i>, <i>KRAS-</i> or <i>MYC-</i>Driven Cell Growth ...
There is an error in the bond configuration for the linearmycin B structure depicted in Fig 1D. Plea...
<p>Correction: In Vitro and In Vivo Metabolism and Inhibitory Activities of Vasicine, a Potent Acety...
Correction: Two-Step Synthesis and Hydrolysis of Cyclic di-AMP in <i>Mycobacterium tuberculosis</i
<p>Correction: Mechanism of Inhibition of the Human Sirtuin Enzyme SIRT3 by Nicotinamide: Computatio...
d-Cycloserine is a second-line drug approved for use in the treatment of patients infected with <i>M...
<p>Correction: The <i>Mycobacterium tuberculosis</i> ClpP1P2 Protease Interacts Asymmetrically with ...
<p>Correction: Identification of Rv3852 as an Agrimophol-Binding Protein in <i>Mycobacterium tubercu...
<p>Correction: Crystal Structures of the Kinase Domain of the Sulfate-Activating Complex in <i>Mycob...
Correction to “Elucidation of a Novel Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as ...
<p>Correction: LprG-Mediated Surface Expression of Lipoarabinomannan Is Essential for Virulence of <...
Correction: A Novel Role of the PrpR as a Transcription Factor Involved in the Regulation of Methylc...
<p>Correction: Human and Murine Clonal CD8+ T Cell Expansions Arise during Tuberculosis Because of T...
Figure 3 is incorrect. The asterisks indicating statistical signif-icance were inadvertently left ou...
Tuberculosis is a disease that is one of the leading ten causes of death worldwide and is believed t...
<p>Correction: Selective Targeting of <i>CTNNB1-</i>, <i>KRAS-</i> or <i>MYC-</i>Driven Cell Growth ...
There is an error in the bond configuration for the linearmycin B structure depicted in Fig 1D. Plea...
<p>Correction: In Vitro and In Vivo Metabolism and Inhibitory Activities of Vasicine, a Potent Acety...
Correction: Two-Step Synthesis and Hydrolysis of Cyclic di-AMP in <i>Mycobacterium tuberculosis</i
<p>Correction: Mechanism of Inhibition of the Human Sirtuin Enzyme SIRT3 by Nicotinamide: Computatio...
d-Cycloserine is a second-line drug approved for use in the treatment of patients infected with <i>M...
<p>Correction: The <i>Mycobacterium tuberculosis</i> ClpP1P2 Protease Interacts Asymmetrically with ...
<p>Correction: Identification of Rv3852 as an Agrimophol-Binding Protein in <i>Mycobacterium tubercu...
<p>Correction: Crystal Structures of the Kinase Domain of the Sulfate-Activating Complex in <i>Mycob...
Correction to “Elucidation of a Novel Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as ...
<p>Correction: LprG-Mediated Surface Expression of Lipoarabinomannan Is Essential for Virulence of <...
Correction: A Novel Role of the PrpR as a Transcription Factor Involved in the Regulation of Methylc...
<p>Correction: Human and Murine Clonal CD8+ T Cell Expansions Arise during Tuberculosis Because of T...
Figure 3 is incorrect. The asterisks indicating statistical signif-icance were inadvertently left ou...
Tuberculosis is a disease that is one of the leading ten causes of death worldwide and is believed t...
<p>Correction: Selective Targeting of <i>CTNNB1-</i>, <i>KRAS-</i> or <i>MYC-</i>Driven Cell Growth ...
There is an error in the bond configuration for the linearmycin B structure depicted in Fig 1D. Plea...
<p>Correction: In Vitro and In Vivo Metabolism and Inhibitory Activities of Vasicine, a Potent Acety...
DOI
Add to ORKG